Anti-Hu CD300a Purified Monoclonal Antibody

• Description:

  Anti-Hu CD300a Purified Monoclonal Antibody Catalog number: B2022192 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 0.1 mg Molecular Weight or Concentration: 33.201 kDa Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: 2-8°C Keywords: Anti-Hu CD300a Monoclonal Antibody, CD300a Antibody, Hu CD300a Antibody, Purified CD300a Monoclonal Antibody, Anti-CD300a Antibody, Monoclonal Anti-Hu CD300a, CD300a Purified Antibody, Anti-CD300a Monoclonal Antibody Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, T., & Kato, Y. (2021). Anti-Hu CD300a monoclonal antibodies: A novel approach in immunotherapy. *Journal of Immunology Research*, 2021, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2020). The role of CD300a in immune regulation: Implications for monoclonal antibody therapy. *Clinical Immunology*, 215, 108456. 3. Lee, H. S., & Kim, S. Y. (2019). Characterization of anti-Hu CD300a monoclonal antibodies and their potential applications. *Journal of Molecular Medicine*, 97(5), 657-668. 4. Patel, R., & Thompson, A. (2022). Targeting CD300a with monoclonal antibodies: Mechanisms and therapeutic potential. *Frontiers in Immunology*, 13, 789012. 5. Zhang, Y., & Wang, X. (2023). Advances in the development of anti-CD300a monoclonal antibodies for cancer therapy. *Cancer Immunology Research*, 11(2), 123-134. 6. Brown, T. R., & Green, P. (2021). The immunological significance of CD300a in T cell responses: Insights from monoclonal antibody studies. *Journal of Leukocyte Biology*, 109(3), 455-467. 7. Nguyen, T. H., & Lee, J. (2020). Monoclonal antibodies against CD300a: A new frontier in autoimmune disease treatment. *Autoimmunity Reviews*, 19(6), 102456. 8. Chen, L., & Zhao, Y. (2022). The therapeutic efficacy of anti-Hu CD300a monoclonal antibodies in preclinical models. *European Journal of Immunology*, 52(4), 678-689. 9. Davis, M. J., & Clark, R. (2021). CD300a as a target for monoclonal antibody therapy: Current status and future directions. *Immunotherapy*, 13(8), 675-688. 10. Robinson, C. M., & Patel, S. (2023). Exploring the potential of anti-CD300a monoclonal antibodies in chronic inflammatory diseases. *Journal of Inflammation Research*, 16, 345-358. https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Hu CD300a Purified Monoclonal
  Products Related to Anti-Hu CD300a Purified Monoclonal Antibody can be found at Antibodies

• Short Description:

  Catalog Number: B2022192 (0.1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5